98
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association Between Weight Change During Adulthood and Chronic Kidney Disease: Results from a National Survey 2011–2018

ORCID Icon, ORCID Icon & ORCID Icon
Pages 3817-3826 | Received 09 Sep 2023, Accepted 12 Nov 2023, Published online: 22 Nov 2023

References

  • Bikbov B, Purcell CA, Levey AS. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–733. doi:10.1016/S0140-6736(20)30045-3
  • Zhu P, Herrington WG, Haynes R, et al. Conventional and genetic evidence on the association between adiposity and CKD. J Am Soc Nephrol. 2021;32(1):127–137. doi:10.1681/ASN.2020050679
  • Kjaergaard AD, Teumer A, Witte DR, et al. Obesity and kidney function: a Two-Sample Mendelian Randomization Study. Clin Chem. 2022;68(3):461–472. doi:10.1093/clinchem/hvab249
  • Foster MC, Hwang S-J, Larson MG, et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis. 2008;52(1):39–48. doi:10.1053/j.ajkd.2008.03.003
  • Naderi N, Kleine C-E, Park C, et al. Obesity paradox in advanced kidney disease: from bedside to the bench. Prog Cardiovasc Dis. 2018;61(2):168–181. doi:10.1016/j.pcad.2018.07.001
  • Ku E, Kopple JD, Johansen KL, et al. Longitudinal weight change during CKD progression and its association with subsequent mortality. Am J Kidney Dis. 2018;71(5):657–665. doi:10.1053/j.ajkd.2017.09.015
  • Ryu H, Hong Y, Kang E, et al. Rapid weight change over time is a risk factor for adverse outcomes in patients with predialysis chronic kidney disease: a Prospective Cohort Study. J Ren Nutr. 2021;31(6):569–578. doi:10.1053/j.jrn.2021.01.026
  • Toda A, Hara S, Tsuji H, et al. Effects of body weight change on development of chronic kidney disease in obese metabolic phenotypes. Nephron. 2022;146(5):449–456.
  • Ryu S, Chang Y, Woo H-Y, et al. Changes in body weight predict CKD in healthy men. J Am Soc Nephrol. 2008;19(9):1798–1805. doi:10.1681/ASN.2007121286
  • Sheehan TJ, DuBrava S, DeChello LM, et al. Rates of weight change for black and white Americans over a twenty year period. Int J Obes Relat Metab Disord. 2003;27(4):498–504. doi:10.1038/sj.ijo.0802263
  • Chen C, Ye Y, Zhang Y, et al. Weight change across adulthood in relation to all cause and cause specific mortality: prospective cohort study. BMJ. 2019;367:l5584. doi:10.1136/bmj.l5584
  • Wang L, Yi J, Guo J, et al. Weigh change across adulthood is related to the presence of NAFLD: results from NHANES III. J Transl Med. 2023;21(1):142. doi:10.1186/s12967-023-04007-8
  • Power C, Thomas C. Changes in BMI, duration of overweight and obesity, and glucose metabolism: 45 years of follow-up of a birth cohort. Diabetes Care. 2011;34(9):1986–1991. doi:10.2337/dc10-1482
  • Lamichhane AP, Couper D, Jenkins GP, et al. Longitudinal associations between body mass index during young adulthood, subsequent weight change, and incident diabetes during mid- and older-adulthood in non-Hispanic white and African American Populations: the Atherosclerosis Risk in Communities Study. Metab Syndr Relat Disord. 2020;18(7):313–320. doi:10.1089/met.2020.0005
  • Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–830. doi:10.7326/0003-4819-158-11-201306040-00007
  • Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737–1749. doi:10.1056/NEJMoa2102953
  • C-y H, McCulloch CE, Iribarren C, et al. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144(1):21–28. doi:10.7326/0003-4819-144-1-200601030-00006
  • Chang AR, Grams ME, Ballew SH, et al. Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium. BMJ. 2019;364:k5301. doi:10.1136/bmj.k5301
  • Betzler BK, Sultana R, Banu R, et al. Association between body mass index and chronic kidney disease in Asian populations: a participant-level meta-analysis. Maturitas. 2021;154:46–54. doi:10.1016/j.maturitas.2021.09.005
  • Garofalo C, Borrelli S, Minutolo R, et al. A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. Kidney Int. 2017;91(5):1224–1235. doi:10.1016/j.kint.2016.12.013
  • Sharma I, Liao Y, Zheng X, et al. New pandemic: obesity and associated nephropathy. Front Med. 2021;8:673556. doi:10.3389/fmed.2021.673556
  • Brennan E, Kantharidis P, Cooper ME, et al. Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function. Nat Rev Nephrol. 2021;17(11):725–739. doi:10.1038/s41581-021-00454-y
  • Tonneijck L, Muskiet MHA, Smits MM, et al. Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment. J Am Soc Nephrol. 2017;28(4):1023–1039. doi:10.1681/ASN.2016060666
  • Henegar JR, Bigler SA, Henegar LK, et al. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol. 2001;12(6):1211–1217. doi:10.1681/ASN.V1261211
  • Khedr A, Khedr E, House AA. Body mass index and the risk of progression of chronic kidney disease. J Ren Nutr. 2011;21(6):455–461. doi:10.1053/j.jrn.2010.12.001
  • Park J, Ahmadi S-F, Streja E, et al. Obesity paradox in end-stage kidney disease patients. Prog Cardiovasc Dis. 2014;56(4):415–425. doi:10.1016/j.pcad.2013.10.005
  • Stack AG, Murthy BVR, Molony DA. Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States. Kidney Int. 2004;65(6):2398–2408. doi:10.1111/j.1523-1755.2004.00654.x
  • Kalantar-Zadeh K, Streja E, Molnar MZ, et al. Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis. Am J Epidemiol. 2012;175(8):793–803. doi:10.1093/aje/kwr384
  • Park SY, Wilkens LR, Maskarinec G, et al. Weight change in older adults and mortality: the Multiethnic Cohort Study. Int J Obes. 2018;42(2):205–212. doi:10.1038/ijo.2017.188
  • Myrskylä M, Chang VW. Weight change, initial BMI, and mortality among middle- and older-aged adults. Epidemiology. 2009;20(6):840–848. doi:10.1097/EDE.0b013e3181b5f520
  • Ingram DD, Mussolino ME. Weight loss from maximum body weight and mortality: the third national health and nutrition examination survey linked mortality file. Int J Obes. 2010;34(6):1044–1050. doi:10.1038/ijo.2010.41
  • Ku E, Kopple JD, McCulloch CE, et al. Associations between weight loss, kidney function decline, and risk of ESRD in the Chronic Kidney Disease in Children (CKiD) Cohort Study. Am J Kidney Dis. 2018;71(5):648–656. doi:10.1053/j.ajkd.2017.08.013
  • Yun H-R, Kim HW, Chang TI, et al. Increased risk of chronic kidney disease associated with weight gain in healthy adults: insight from metabolic profiles and body composition. Front Med. 2021;8:705881. doi:10.3389/fmed.2021.705881
  • Zhang H-S, An S, Ahn C, et al. Obesity measures at baseline, their trajectories over time, and the incidence of chronic kidney disease: a 14 year cohort study among Korean adults. Nutr, Metab Cardiovasc Dis. 2021;31(3):782–792. doi:10.1016/j.numecd.2020.10.021
  • Chung HF, Al Mamun A, Huang MC, et al. Obesity, weight change, and chronic kidney disease in patients with type 2 diabetes mellitus: a longitudinal study in Taiwan: 2. J Diabetes. 2017;9(11):983–993. doi:10.1111/1753-0407.12514
  • Pan X-F, Yuan J-M, Koh W-P, et al. Weight change in relation to mortality in middle-aged and elderly Chinese: the Singapore Chinese Health Study. Int J Obes. 2019;43(8):1590–1600. doi:10.1038/s41366-018-0259-y
  • Cheng FW, Gao X, Jensen GL. Weight change and all-cause mortality in older adults: a meta-analysis. J Nutr Gerontol Geriatr. 2015;34(4):343–368. doi:10.1080/21551197.2015.1090362
  • Karahalios A, English DR, Simpson JA. Change in body size and mortality: a systematic review and meta-analysis. Int J Epidemiol. 2017;46(2):526–546. doi:10.1093/ije/dyw246
  • Amdur RL, Feldman HI, Gupta J, et al. Inflammation and progression of CKD: the CRIC Study. Clin J Am Soc Nephrol. 2016;11(9):1546–1556. doi:10.2215/CJN.13121215
  • Look AHEAD Research Group. Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2014;2(10):801‐809.
  • Moncrieft AE, Llabre MM, McCalla JR, et al. Effects of a multicomponent life-style intervention on weight, glycemic control, depressive symptoms, and renal function in low-income, minority patients with type 2 diabetes: results of the community approach to lifestyle modification for diabetes randomized controlled trial. Psychosomatic Med. 2016;78(7):851–860. doi:10.1097/PSY.0000000000000348
  • Simonsen MK, Hundrup YA, Obel EB, et al. Intentional weight loss and mortality among initially healthy men and women. Nutr Rev. 2008;66(7):375–386. doi:10.1111/j.1753-4887.2008.00047.x
  • Lee SW, Son JY, Kim JM, et al. Body fat distribution is more predictive of all-cause mortality than overall adiposity. Diabetes Obes Metab. 2018;20(1):141–147. doi:10.1111/dom.13050